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 Abstract 
 Background: Lymphoedema represents the cardinal manifestation of lymphatic dysfunction 
and is associated with expansion of the adipose tissue in the affected limb. In mice, high-fat 
diet (HFD)-induced obesity was associated with impaired collecting lymphatic vessel function, 
and adiposity aggravated surgery-induced lymphoedema in a mouse model. The aim of the 
current study was to investigate whether adiposity is necessary to impair lymphatic function 
or whether increased lipid exposure alone might be sufficient in a surgical lymphoedema 
model.  Methods: To investigate the role of increased lipid exposure in lymphoedema devel-
opment we used a well-established mouse tail lymphoedema model. Female mice were sub-
jected to a short-term (6 weeks) HFD, without development of obesity, before surgical induc-
tion of lymphedema. Lymphoedema was followed over a period of 6 weeks measuring 
oedema, evaluating tissue histology and lymphatic vascular function.  Results: HFD increased 
baseline angiogenesis and average lymphatic vessel size in comparison to the chow control 
group. Upon induction of lymphedema, HFD-treated mice did not exhibit aggravated oedema 
and no morphological differences were observed in the blood and lymphatic vasculature. Im-
portantly, the levels of fibro-adipose tissue deposition were comparable between the 2 groups 
and lymphatic vessel function was not impaired as a result of the HFD. Although the net im-
mune cell infiltration was comparable, the HFD group displayed an increased infiltration of 
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macrophages, which exhibited an M2 polarization phenotype.  Conclusions: These results in-
dicate that increased adiposity rather than dietary influences determines predisposition to or 
severity of lymphedema.  © 2017 S. Karger AG, Basel 
 Introduction 
 The lymphatic system contributes to the maintenance of tissue fluid homeostasis, immune 
surveillance, and lipid metabolism by transporting lipids taken up by the small intestine, and 
also plays a critical role in many pathological conditions  [1] . Dysfunction of the lymphatic 
system leads to accumulation of extravasated fluid and macromolecules, a condition commonly 
recognized as lymphedema. Whereas filariasis, a parasitic mosquito-borne infection, repre-
sents the main cause of lymphoedema in developing countries, in developed countries lymph-
oedema commonly occurs as a post-cancer treatment complication, mainly after surgery for 
breast cancer or other gynaecological cancers  [2] .
 The clinical manifestations of lymphoedema include swelling and a feeling of heaviness 
of the affected limb, immune cell infiltration, and fibrosis  [3] . The oedematous limbs do not 
merely contain fluid but also an increased amount of adipose tissue, and surgical removal 
of adipose tissue improves the course of the disease  [4] . Similar findings in experimental 
models, where lymphoedema results in localized adipose tissue deposition  [5] , indicate a 
clear link between impaired lymphatic transport and localized adipose tissue accumu-
lation.
 There is increasing evidence that obesity constitutes a risk factor for lymphoedema 
development  [6, 7] . Lower extremity lymphoedema has been reported in patients with signif-
icantly elevated body mass index  [8] , and an increased body mass index was also associated 
with lymphoscintigraphic findings of compromised lymphatic vessel function in the affected 
limbs  [9] . A comparison of the lymphatic transport in the subcutaneous adipose tissue of 
obese and lean individuals indicated that the drainage of macromolecules was less efficient 
in obese adipose tissue than in lean adipose tissue since there was an increase in the lymphatic 
drainage rate in the postprandial state versus preprandial state in lean adipose tissue but not 
in the adipose tissue of obese subjects  [10] . These data suggest a causal role of obesity in 
lymphatic insufficiency.
 While the lipid transport function of lymphatic vessels was identified as early as the 17th 
century by Gaspare Asseli  [11] , the interplay between the lymphatic system and the adipose 
tissue has been largely overlooked until recently  [12] . In a genetic mouse model with a 
defective lymphatic system, namely Prox-1 heterozygous mice, lymphatic leakage was 
observed together with late-onset obesity  [13] . Importantly, the obesity phenotype could be 
reversed after Prox-1 expression was specifically rescued in the lymphatic vessels  [14] , indi-
cating that the lymphatic dysfunction in those mice was responsible for the obesity. In exper-
imental mouse models of diet-induced obesity, chronic high-fat diet (HFD) and obesity 
resulted in impaired collecting lymphatic vessel function  [15] as well as impaired dendritic 
cell migration to the lymph nodes  [16] , whereas diet-induced visceral fat accumulation has 
been reported to lead to atrophy of the mesenteric lymph nodes in obese mice  [17] . 
Furthermore, HFD-induced obesity aggravated inflammation and fibrotic tissue deposition in 
a murine model of lymphoedema  [16] . 
 Lymphatic dysfunction was also found in mouse models of dyslipidaemia. For instance, 
hypercholesterolaemic mice exhibited lymphatic vessel dysfunction with tissue swelling, 
lymphatic leakage, decreased lymphatic transport, and abnormal lymphatic morphology 
 [18] . Additionally, recent reports indicate a potential link between impaired lymphatic vessel 
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function, lipoprotein metabolism, increased plasma cholesterol levels, and enhanced athero-
sclerosis  [19] .
 In most of the aforementioned studies, obesity was induced by HFD feeding, which then 
ultimately resulted in impaired lymphatic transport. It has remained unclear, however, 
whether these effects were due to obesity or due to the HFD itself. The purpose of this study 
was to examine the effect of HFD alone on the lymphatic vasculature and on the course of 
experimentally induced lymphedema. We used a murine model of surgically induced secondary 
lymphedema, using female mice, which do not develop obesity under HFD  [17] . HFD alone 
resulted in a baseline increase in the tissue area covered by blood and lymphatic vessels. Upon 
lymphoedema induction, both groups exhibited comparable swelling and no significant 
morphological differences in the blood and lymphatic vasculature were detected. No differ-
ences in fibrotic and adipose tissue deposition were observed between the 2 groups and the 
contractility of collecting lymphatic vessels was not impaired as a result of the diet. Despite 
the comparable net immune cell infiltration, the HFD group exhibited an increased infiltration 
of M2-type macrophages in the skin. Together, these results indicate that HFD in the absence 
of obesity is not sufficient to aggravate surgically induced secondary lymphedema.
 Materials and Methods 
 Mice and Diet 
 Female C57BL/6 mice were kept under conventional SPF conditions. Female mice were selected based 
on the relevance of lymphoedema as a post-breast-cancer treatment complication mainly affecting women. 
Starting at 4 weeks of age, half of the mice were provided ad libitum access to standard chow diet (chow; 11% 
kcal deriving from fat, 31% kcal from protein, and 58% from carbohydrates; Provimi-Kliba, Kaiseraugst, 
Switzerland) and the other half to HFD (60% kcal deriving from lard [pig fat], 20% kcal from protein, and 
20% from carbohydrates; Research Diets Inc., New Brunswick, NJ, USA). Mice were kept on chow/HFD for
6 weeks before being operated, and thereafter until the time of sacrifice. The Cantonal Veterinary Office
of Zurich (Kantonales Veterinäramt Zürich) approved the current study (Animal License 225/2013).
 Lymphoedema Model 
 Mice were operated at the age of 10 weeks as previously described  [20, 21] . Briefly, mice were anaes-
thetized with isoflurane (2.5%). A circumferential portion of full-thickness skin, 4–5 mm wide, was excised 
2 cm below the base of the tail. Subsequently, the collecting lymphatic vessels running along the lateral tail 
veins were identified under a dissecting microscope and were excised, sparing the veins. Mice were moni-
tored for 3 consecutive days following the operation and thereafter once weekly until the termination of the 
study.
 In vivo Imaging of Lymphatic Vessel Contractility 
 Mice were anaesthetized by intraperitoneal injection of 0.2 mg/kg medetomidine and 80 mg/kg 
ketamine before imaging. A Zeiss StereoLumar V12 stereomicroscope, adapted for near-infrared imaging, 
was used for lymphatic imaging  [22] . A Harvard Apparatus PHD2000 syringe pump and a custom-made 
intradermal catheter consisting of PE10 tubing and a 30-g needle were used to inject a bolus of 5 μL of 20 μ M 
of the PEGylated near-infrared dye P20D800  [22] at approximately 1 cm proximal to the tail tip, followed by 
controlled infusion of an additional 1 μL at a rate of 0.2 μL/min. During the controlled infusion, a 15-min 
video was recorded 1–2 cm distal to the wound site. On the video recording, a region of interest analysis of 
fluorescent intensity was performed using Zeiss AxioVision software to evaluate the contractile function of 
the collecting lymphatic vessels. A custom software in Matlab  [23] was used to analyse the frequency (in 
contractions per min) and amplitude (in % of mean fluorescence intensity) of the contractions. The pumping 
score was calculated as a product of frequency and amplitude.
 Evaluation of Tail Oedema and Histological Analyses 
 Tail oedema was evaluated with single diameter measurements 4–5 mm distal to the excision margin, 
using a digital calliper at the indicated time points (prior to operation, 2 weeks and 6 weeks postoperatively).
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 Cryosections (7 μm) were obtained from a 2- to 3-mm portion of tail skin 1 cm distal to the excision 
margin and were embedded in OCT. Cryosections were fixed for 2 min in acetone (–20  °  C) and for 5 min in 
80% methanol (4  °  C), washed in PBS, incubated for 2 h at 4  °  C in “immunomix” (5% normal donkey serum, 
0.2% bovine serum albumin in PBS with 0.3% Triton X) and incubated overnight (4  °  C) in immunomix with 
the following antibodies: goat anti-LYVE-1 (1: 600, AngioBio), rat anti-Meca-32 (1: 200, BD Bioscience), goat 
anti-CD45 (1: 100, R&D Systems), rat anti-CD68 (1: 200, Abcam) or goat anti-CD206 (1: 200, R&D Systems). 
The samples were then incubated with Alexa488- and Alexa594-conjugated secondary antibodies (1: 200) 
and Hoechst 33342 (1: 1,000, all from Invitrogen), diluted in PBS, for 30 min. Sections were coverslipped with 
Mowiol (Calbiochem).
 Determination of Lipid and Collagen Content 
 Lipid deposition was evaluated using the BODIPY stain on tail cryosections. In brief, 7-μm-thick sections 
were fixed with 4% PFA for 15 min, washed and incubated with BODIPY 493/503 (1: 2,000, Life Technol-
ogies) and Hoechst 33342 (Invitrogen) diluted in Dako diluent (Dako) for 30 min, and then washed again and 
mounted with Mowiol. 
 Collagen content was evaluated on paraffin sections stained with picrosirius red  [21] . Tail samples (3- 
to 4-mm thick cross-sections) were obtained 0.5–1 cm distal to the excision margin, fixed in 4% PFA for 4 h 
at 4 ° C and then decalcified for 7 days using EDTA 0.5  M , exchanged daily. Tissues were embedded in paraffin 
and 5-μm-thick sections were obtained. After deparaffinization and rehydration, the sections were stained 
with picrosirius red (Sigma-Aldrich) for 1 h and then washed in acidified water (0.5% acetic acid in water). 
Sections were cleared with xylol, drained, and then mounted with Eukitt medium (Fluka).
 Morphometric and Morphologic Analyses 
 Immunofluorescence stains of tail skin sections were examined with an Axioskop 2 mot plus microscope 
(Carl Zeiss) equipped with an Illuminator HXP 120 and an AxioCam MRc camera, and 5–6 images per tissue 
section were acquired with a Plan Apochromat ×10/0.45 NA objective. Picrosirius images were obtained 
using an EC Plan-Neofluar ×2.5/0.075 objective (Axioskop 2 mot plus) or a Panoramic Slide Scanner 250 BF 
Flash (3D Histech, Ramsey, NJ, USA) equipped with a Brightfield CIS 3CCD VCC-F52U25CL with a ×20/0.8 NA 
objective, acquiring and evaluating 1–3 images per tissue section. Morphometric analysis of the vessels, 
immune cells, and collagen content was performed with ImageJ software.
 Statistical Analyses 
 All data represent mean ± SD and sample sizes and the statistical analyses are indicated in the Figure 
legends. Means of 2 groups were compared with a two-tailed Student t test; a Welch correction was applied 
in case of unequal variances. Weight gain data were analysed with a 2-way ANOVA. Analyses were performed 
using GraphPad Prism V6.0 (GraphPad Software, San Diego, CA, USA), SPSS version 22.0 (SPSS Inc., Chicago, 
IL, USA) or Matlab version 7.12.0.635 R2011a (Mathworks, Inc.).  p <  0.05 was accepted as statistically signif-
icant.
 Results 
 HFD without Obesity Is Not Sufficient to Aggravate Swelling during Lymphoedema 
Development 
 To study the effects of HFD in the absence of obesity, 4-week-old female C57BL/6 mice 
were fed with regular mouse chow or HFD for a period of 6 weeks before surgical induction 
of lymphedema, and were then kept on the corresponding diets until the end of the experi-
ments ( Fig. 1 a). At 10 weeks of age, before lymphoedema was induced, the mice under HFD 
exhibited a modest weight increase compared to chow-fed mice (chow: 19.9 ± 0.9 g,  n = 5; 
HFD: 21.7 ± 1.2 g,  n = 5;  p = 0.0299) as well as elevated serum triglyceride levels (see online 
suppl. Fig. 1; for all online suppl. material, see www.karger.com/doi/10.1159/000461579). 
At 12 weeks of age (2 weeks postoperatively), the weight was not significantly different 
between the 2 groups (chow: 20.1 ± 0.6 g,  n = 7; HFD: 21.2 ± 1.7 g,  n = 6;  p = 0.1680), whereas 
HFD mice were significantly heavier at 6 weeks after the operation (chow week 6: 21.3 ± 1.1 
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g,  n = 8; HFD: 25.2 ± 2.4 g,  n = 8;  p = 0.0008;  Fig. 1 b). Comparison of oedema development was 
based on the evaluation of tail diameters, measured 2.5 cm distal to the tail base ( Fig. 1 c). At 
2 weeks postoperatively, the increase in tail diameters in comparison to the preoperative 
values was comparable between the 2 groups (chow: 156.2 ± 12.8%,  n = 7; HFD: 157.3 ± 
10.4%,  n = 5;  p < 0.0001;  Fig. 1 d). However, at 6 weeks postoperatively, the tail thickness 
increase was significantly lower in the HFD group (chow: 163.9 ± 26.5%,  n = 8; HFD: 136.1 ± 
12.4%,  n = 6;  p = 0.0353;  Fig. 1 d), probably because of the slightly increased baseline tail 
thickness observed in the HFD mice (chow: 3.1 ± 0.1 mm,  n = 5; HFD: 3.4 ± 0.2 mm,  n = 5;  p = 
0.0026; data not shown) that was likely due to increased adipose tissue accumulation.
 HFD without Obesity Does Not Increase Fibro-Adipose Tissue Accumulation in 
Lymphedema 
 Fibrosis and adipose tissue accumulation are hallmarks of lymphoedema development 
 [3] ; therefore, we next investigated whether there were any differences of collagen or lipid 
deposition between the chow and HFD groups. Fibrosis was evaluated on tail tissue cross-
sections by picrosirius red staining that depicts collagenous tissue ( Fig. 2 a). Quantification of 
stained sections revealed an increased collagen deposition in the tails of the unoperated HFD 
group as compared to the unoperated chow group (chow: 0.2774 ± 0.09 mm 2 ,  n = 5; HFD: 
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0.4216 ± 0.08 mm 2 ,  n = 5;  p = 0.0261;  Fig. 2 b), but no difference was seen between the groups 
at 2 and 6 weeks after lymphoedema surgery. Quantification of lipid deposition using the 
BODIPY lipid stain showed a minor, nonsignificant increase in lipid accumulation in the tail 
skin of HFD mice at all investigated time points ( Fig. 2 c, d).
 HFD without Obesity Does Not Affect Blood or Lymphatic Vessel Morphology in 
Lymphedema 
 Lymphatic vascular remodelling occurs during lymphoedema development and is asso-
ciated with the severity of the disease  [21] . We next investigated blood and lymphatic vessels 
in tissue sections stained for the lymphatic marker LYVE-1 and the blood vascular marker 
Meca-32 before and after lymphoedema induction ( Fig. 3 a). In unoperated mice, 6 weeks of 
HFD led to an increase in the tissue area occupied by blood vessels (chow: 1.6 ± 0.4%,  n = 5; 
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HFD: 2.6 ± 0.4%,  n = 5;  p = 0.0095) and by lymphatic vessels (chow: 2.1 ± 0.7%,  n = 5; HFD: 
3.2 ± 0.5%,  n = 5;  p = 0.0127;  Fig. 3 b, c) and the average size of lymphatic vessels was signifi-
cantly larger (chow: 451.6 ± 46.4 μm 2 ,  n = 5; HFD: 802.0 ± 199.2 μm 2 ,  n = 5;  p = 0.0154; 
 Fig. 3 d). Upon induction of lymphedema, the blood vascular coverage did not significantly 
differ between the 2 groups, but the lymphatic vessel area was increased in both groups, as 
compared to unoperated mice. There were no significant differences between the HFD and 
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chow group ( Fig. 3 a–c). There was a trend towards larger lymphatic vessels in the HFD group 
2 weeks postoperatively (chow: 2,373.0 ± 855.2 μm 2 ,  n = 6; HFD: 3,411 ± 889.1 μm 2 ,  n = 6;
 p = 0.0664;  Fig. 3 d), whereas there were no major differences after 6 weeks.
 Collecting Lymphatic Vessel Contractility in Lymphoedema Is Not Affected by HFD  
 We next investigated the functionality of the collecting lymphatic vessels before and after 
induction of lymphoedema with video acquisitions of the lymphatic vessel transport of an 
infrared tracer that was injected near the tip of the tail. We employed a region of interest 
analysis on the collecting lymphatic vessels in an area 1–2 cm distal to the operation site to 
quantify the contraction amplitude and frequency  [23] . The contraction patterns in unoperated 
mice as well as 1 week and 6 weeks following operation were similar in both groups ( Fig. 4 a). 
While the contraction amplitude at 1 week and 6 weeks postoperatively was lower than in 
unoperated mice, quantitative analyses did not reveal any significant changes in the amplitude 
or the contraction frequency between the 2 diet groups at any of the investigated time points 
( Fig. 4 b, c). Consequently, there were no major differences in the pumping score, calculated as 
the product of contraction amplitude and frequency, between the 2 groups ( Fig. 4 d).
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a
 Fig. 4. Quantitative evaluation of collecting lymphatic vessel contractility of chow- and HFD-fed mice.  a Rep-
resentative contractility patterns detected in unoperated tails and in tails 1 week and 6 weeks after lymph-
oedema surgery, indicating a lower amplitude during lymphoedema development without major differences 
between the chow and HFD groups. Quantification of the contraction amplitude ( b ), contraction frequency 
( c ), and pumping score ( d ; amplitude × frequency) revealed no major changes between the 2 groups. Means 
of 2 groups (chow-HFD) were compared with a two-tailed Student  t test.  n = 4–7 per group. 
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 HFD Promotes M1 and M2 Macrophage Infiltration into Skin  
 Skin inflammation is one of the main characteristics of lymphedema. We first investi-
gated the immune cell infiltration using immunofluorescence stains for CD45. The extent of 
CD45-positive cell infiltration increased during lymphoedema development but was compa-
rable in both groups at all time points ( Fig. 5 a, b). Evaluation of macrophage infiltration using 
immunostains for CD68 revealed a significantly increased presence of CD68+ cells (expressed 
as % area positive for CD68) in the HFD-fed group without operation (chow: 1.50 ± 1.0%,  n = 
5; HFD: 6.2 ± 2.6%,  n = 5;  p = 0.0052). At 2 and 6 weeks, macrophage infiltration was further 
increased in both groups but was always significantly higher in the HFD group  (chow week 
2: 5.0 ± 2.4%,  n = 6; HFD week 2: 11.2 ± 2.3%,  n = 5;  p = 0.0021; chow week 6: 5.7 ± 2.6%,  n = 
5; HFD week 6: 11.7 ± 3.2%,  n = 5;  p = 0.0117;  Fig. 5 c, d). Further characterization of the 
macrophage populations, staining for M2-polarized macrophages using the marker CD206, 
indicated a strong, persistent infiltration of CD206+ macrophages in unoperated HFD mice 
(chow: 1.8 ± 0.4%,  n = 5; HFD: 5.1 ± 0.9%,  n = 5;  p < 0.0001), which was maintained 2 and 6 
weeks postoperatively (chow week 2: 1.8 ± 0.8%,  n = 6; HFD week 2: 5.7 ± 1.4%,  n = 5;  p = 
0.0002; chow week 6: 2.6 ± 1.3%,  n = 5; HFD week 6: 8.4 ± 4.1%,  n = 5;  p = 0.0302;  Fig. 5 c, e). 
Evaluation of the M1/M2 ratio on a transcriptional level using CD11c and iNOS as M1 markers 
and CD206 as M2 markers revealed no differences in the macrophage infiltrate preopera-
tively or during the early stage of lymphoedema development but a striking increase in the 
M1/M2 ratio 6 weeks postoperatively (CD11c/CD206 chow: 3.0 ± 1.3, HFD: 10.3 ± 2.2,  p = 
0.0013; iNOS/CD206 chow: 0.6 ± 0.1, HFD: 6.9 ± 0.9,  p = 0.0006; see online suppl. Fig. 2). 
 Discussion 
 Lymphoedema is the ultimate consequence of lymphatic dysfunction and is usually a 
iatrogenic complication following surgical cancer treatment. Recently, it was proposed that 
obesity might aggravate lymphoedema  [16] . Indeed, several studies in patients and experi-
mental rodent models of obesity and metabolic syndrome revealed that obesity is related to 
impaired lymphatic transport capacity, aggravated inflammation, and increased fibrosis 
 [8–10, 15, 16] . While the aforementioned human studies suggested an association between 
obesity and impaired lymphatic function, experimental rodent models revealed that diet-
induced obesity caused lymphatic insufficiency  [15] . However, these experimental studies 
did not identify whether the HFD or the increased adiposity caused the impairment of 
lymphatic function. In the present study, we show that this effect is most likely due to obesity 
and not to HFD.
 In our experimental model, HFD in the absence of obesity induced a moderate but signif-
icant increase in the area covered by blood and lymphatic vessels in the skin and in the 
 Fig. 5. Evaluation of the immune cell infiltrate in lymphoedema indicates increased M2 macrophage infiltra-
tion in the HFD group.  a Immunofluorescence stains of 7-μm-thick cryosections for the pan-hematopoietic 
marker CD45 (green). Hoechst nuclear counterstain (blue).  b Quantification of the CD45+ cell infiltrate re-
vealed no major differences between the 2 groups at all examined time points.  c Immunofluorescence stains 
for CD68 (green; all monocytes and macrophages) and CD206 (red; M2-like macrophages) in cryosections. 
 d ,  e Quantification of the CD68 and CD206 immunostains revealed increased CD68+ macrophage and CD206+ 
cell infiltrates in the HFD-treated group at all time points. The means of the 2 groups were compared with a 
two-tailed Student t test, applying Welch correction when necessary. Asterisks indicate statistical signifi-
cance ( *  p < 0.05,  * *  p < 0.01,  * * *  p < 0.001).  n = 6 per group. Scale bar = 100 μm. For colours, see online ver-
sion. 
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average lymphatic vessel size in unoperated mice. Indeed, HFD has been reported to induce 
angiogenesis in the skeletal muscle and to activate angiogenic pathways in blood capillaries 
 [24] . At week 2 after lymphoedema induction, the lymphatic vessel size was increased in both 
groups, in line with studies showing that lymphatic remodelling occurs as a response to 
increased tissue oedema  [21, 25] but no differences were observed between the 2 groups. 
Importantly, HFD did not result in any changes in the deposition of fibrotic and adipose tissue, 
2 hallmarks of lymphedema, and the contractility of collecting lymphatic vessels was not 
further impaired as a result of the diet. Recent work has demonstrated that lymphatic vessel 
function is protected in obesity-resistant mice in comparison to obesity-prone mice and the 
functional impairment is associated with significant changes in the perilymphatic inflam-
mation  [26] .
 A major finding of the present study was the alteration of the immune compartment in the 
lymphoedematous skin under HFD. Despite similar trends for CD45+ hematopoietic 
compartment cells in both groups over the course of lymphoedema development, mice on HFD 
had an increased infiltration by CD68+ monocytes/macrophages compared to controls at all 
examined time points. Although it is well established that adiposity is associated with increased 
macrophage infiltration  [27] , it is a novel finding that HFD without obesity suffices to increase 
macrophage infiltration. Moreover, it is of interest that this increase initially correlated with 
an increase in CD206+ cells. CD206 is generally considered an alternative activation (M2 
macrophage) marker  [28] . Alternatively polarized macrophages have known angiogenic prop-
erties and this could explain the increased baseline blood vessel coverage observed in the tail 
skin  [29, 30] . Despite a significant increase in M2 macrophage markers, we also found a 
profound increase in the M1/M2 ratio in the HFD group 6 weeks postoperatively suggesting 
an even greater increase in the M1 macrophage compartment in the HFD group. This is in line 
with a recent study where HFD-induced obesity led to an increase in both M1 and M2 macro-
phages, with an increase in the M1/M2 ratio  [31] . We observed a subtle increase in the lipid 
content of the skin as shown by BODIPY staining; hence, it is plausible that an increase in the 
skin lipids in HFD-fed mice might contribute to recruiting M2 macrophages or polarizing 
macrophages towards the M2 phenotype. This increase might be enough to recruit immune 
cells bearing the scavenger receptor CD36, which is centrally involved in the lipid uptake 
process  [32] and was shown to be critical for M2 polarization of macrophages  [33] .
 Several studies reported that obesity and metabolic syndrome might impair lymphatic 
function via changing the levels of inflammatory stimuli that might alter endothelial barrier 
functions or diminish the contractility of lymphatic vessels  [34] . For instance, Scallan and 
colleagues  [35, 36] reported that impaired nitric oxide signalling was responsible for 
lymphatic vascular disruption in type 2 diabetes and that the contractility of collecting 
lymphatic vessels was improved upon genetic deletion of basal nitric oxide synthase. Meta-
bolic syndrome was also reported to contribute to the impairment of lymphatic contractility 
in rats fed a high-fructose diet  [37] . In our study, in the absence of obesity, we found no major 
differences in the contractility parameters of the collecting lymphatic vessels upon HFD 
feeding, indicating that HFD without obesity is not sufficient to impair collecting lymphatic 
vessel function. These results are in agreement with findings in a randomized controlled trial 
comparing a low-fat diet (fat intake up to 20% of total energy uptake) with a weight reduction 
diet (introducing a 1,000 kcal daily deficit) and a normal (uncontrolled) diet in breast cancer-
related lymphedema. In this trial, a significant correlation between weight loss and reduction 
of the arm volume was found, indicating that alternation of the diet composition alone without 
weight reduction is not sufficient to reduce the volume of the affected limb in breast cancer-
related lymphoedema  [38, 39] .
 Together, our results indicate that HFD alone does not render mice more susceptible to 
an increased extent of surgically induced lymphedema; however, it leads to a distinct immune 
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cell infiltration in the skin. Our findings indicate that the improvement achieved by dietary 
intervention trials in lymphoedema patients is likely due to reduced adiposity and not to the 
content of the diet.
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